Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia : results from the 24-month follow-up of the BELA trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1111/bjh.13108
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2014
- Urheber
-
Brümmendorf, Tim Henrik
Cortes, Jorge E.
Souza, Cármino Antonio de
Guilhot, Francois
Duvillié, Ladan
Pavlov, Dmitri
Gogat, Karïn
Countouriotis, Athena M.
Gambacorti-Passerini, Carlo
- DOI
-
10.18154/RWTH-2015-05207
- URN
-
urn:nbn:de:101:1-2018110105503583310304
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:46 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Brümmendorf, Tim Henrik
- Cortes, Jorge E.
- Souza, Cármino Antonio de
- Guilhot, Francois
- Duvillié, Ladan
- Pavlov, Dmitri
- Gogat, Karïn
- Countouriotis, Athena M.
- Gambacorti-Passerini, Carlo
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2014
Ähnliche Objekte (12)
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
The impact of newly diagnosed chronic paediatric conditions on parental quality of life
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
Neutrophil biology in chronic lymphocytic leukaemia and infections
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
The impact of newly diagnosed chronic paediatric conditions on parental quality of life
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
Neutrophil biology in chronic lymphocytic leukaemia and infections
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
The impact of newly diagnosed chronic paediatric conditions on parental quality of life
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
Neutrophil biology in chronic lymphocytic leukaemia and infections
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment